This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): A1AT, A1-PI, A1PI, Alpha1-Proteinase Inhibitor (Human), Respreeza (EU)
Description: Alpha1-Proteinase Inhibitor (Human), Zemaira, is a sterile, stable, lyophilized preparation of highly purified human alpha1-proteinase inhibitor (A1-PI), also known as alpha1-antitrypsin, derived from human plasma.
Pink Sheet Aventis Behring Zemaira approval
Additional information available to subscribers only: